
EverQuote, Inc. (NASDAQ:EVER – Free Report) – Equities researchers at William Blair lifted their FY2025 earnings per share (EPS) estimates for shares of EverQuote in a research report issued to clients and investors on Monday, November 3rd. William Blair analyst R. Schackart now forecasts that the company will post earnings per share of $1.73 for the year, up from their prior forecast of $1.57. The consensus estimate for EverQuote’s current full-year earnings is $0.72 per share. William Blair also issued estimates for EverQuote’s Q4 2025 earnings at $0.39 EPS, Q2 2026 earnings at $0.44 EPS, Q3 2026 earnings at $0.48 EPS and Q4 2026 earnings at $0.40 EPS.
EverQuote (NASDAQ:EVER – Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.13. The firm had revenue of $173.94 million for the quarter, compared to the consensus estimate of $166.09 million. EverQuote had a return on equity of 39.65% and a net margin of 8.36%.The firm’s revenue was up 20.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.31 earnings per share. EverQuote has set its Q4 2025 guidance at EPS.
Check Out Our Latest Analysis on EverQuote
EverQuote Stock Performance
Shares of NASDAQ EVER opened at $24.28 on Wednesday. The firm has a market cap of $886.46 million, a price-to-earnings ratio of 16.98 and a beta of 0.53. The business’s 50-day simple moving average is $22.41 and its 200-day simple moving average is $23.54. EverQuote has a 52 week low of $16.63 and a 52 week high of $30.03.
Insider Buying and Selling at EverQuote
In related news, General Counsel Julia Brncic sold 1,436 shares of the stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $23.51, for a total value of $33,760.36. Following the completion of the sale, the general counsel owned 119,676 shares in the company, valued at approximately $2,813,582.76. This trade represents a 1.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO David Brainard sold 5,710 shares of the business’s stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $22.20, for a total value of $126,762.00. Following the transaction, the chief technology officer owned 115,161 shares in the company, valued at $2,556,574.20. This represents a 4.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 958,113 shares of company stock valued at $22,295,496 in the last three months. Company insiders own 25.52% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of EVER. Strategic Blueprint LLC bought a new stake in EverQuote in the 1st quarter valued at $245,000. Concurrent Investment Advisors LLC acquired a new position in EverQuote in the first quarter worth about $244,000. Envestnet Asset Management Inc. acquired a new position in shares of EverQuote in the 1st quarter worth approximately $983,000. Linden Thomas Advisory Services LLC acquired a new stake in EverQuote in the 1st quarter valued at $216,000. Finally, Alps Advisors Inc. acquired a new position in EverQuote during the first quarter worth $335,000. 91.54% of the stock is owned by institutional investors.
EverQuote Company Profile
EverQuote, Inc operates an online marketplace for insurance shopping in the United States. The company offers auto, home and renters, and life insurance. The company serves carriers and agents, as well as indirect distributors. The company was formerly known as AdHarmonics, Inc, and changed its name to EverQuote, Inc in November 2014.
Featured Stories
- Five stocks we like better than EverQuote
- Golden Cross Stocks: Pattern, Examples and Charts
- Affirm’s New York Life Deal: A Game-Changing Stamp of Approval
- How to invest in marijuana stocks in 7 stepsĀ
- 3 Potential Scenarios to Watch for in D-Wave’s Earnings Report
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
